Al-Moghrabi Nisreen M, Al-Sharif Ibtehaj S, Aboussekhra Abdelilah
Department of Biological and Medical Research, King Faisal Specialist Hospital and Research Center, MBC #03, PO Box 3354, Riyadh 11211, Saudi Arabia.
DNA Repair (Amst). 2003 Nov 21;2(11):1185-97. doi: 10.1016/j.dnarep.2003.07.002.
DNA damage results in the up-regulation of several genes involved in different cellular physiological processes, such as the nucleotide excision repair (NER) mechanism that copes with a broad range of DNA alterations, including the carcinogenic ultraviolet (UV) light-induced pyrimidine dimers (PDs). There are two NER sub-pathways: transcription coupled repair (TCR) that is specific for the transcribed strands (TS) of active genes and global genomic repair (GGR) that repairs non-transcribed DNA sequences (NTD) and the non-transcribed strands (NTS) of expressed genes. To elucidate the role of UV-dependent de novo protein synthesis in nucleotide excision repair in the budding yeast, we investigated the effect of the protein synthesis inhibitor, cycloheximide, on the removal of PDs. Log phase as well as G(1)-synchronized cells were treated with the drug shortly before UV irradiation and immediately thereafter, and the repair of damaged DNA was assessed with the high resolution primer extension technique. The results show that in both cellular conditions, the inhibition of UV-dependent de novo protein synthesis by cycloheximide impairs the excision repair of the transcriptionally active GAL10 and URA3 genes, with a greater effect on the non-transcribed strands. This indicates that UV-mediated de novo protein synthesis is required for efficient nucleotide excision repair, but not for the preferential repair of the TSs. On the other hand, cycloheximide did not affect the repair of either strand of the repressed GAL10 gene or the non-transcribed promoter region of the URA3 gene, showing that UV-induced de novo protein synthesis is not required for PD removal from transcriptionally inactive DNA sequences. Together, these data show that despite the fact that NTD and NTSs are normally repaired by the GGR sub-pathway, their requirement for UV-dependent de novo protein synthesis is different, which may suggest a difference in the processing of UV lesions in these non-transcribed sequences of the genome.
DNA损伤会导致参与不同细胞生理过程的多个基因上调,比如核苷酸切除修复(NER)机制,该机制可应对多种DNA改变,包括致癌性紫外线(UV)诱导的嘧啶二聚体(PDs)。NER有两个子途径:转录偶联修复(TCR),它特异性作用于活性基因的转录链(TS);全局基因组修复(GGR),它修复非转录DNA序列(NTD)以及已表达基因的非转录链(NTS)。为阐明紫外线依赖性从头蛋白质合成在芽殖酵母核苷酸切除修复中的作用,我们研究了蛋白质合成抑制剂环己酰亚胺对PDs去除的影响。在紫外线照射前不久及照射后立即用该药物处理对数期以及G1期同步化的细胞,并用高分辨率引物延伸技术评估受损DNA的修复情况。结果表明,在这两种细胞状态下,环己酰亚胺对紫外线依赖性从头蛋白质合成的抑制会损害转录活性GAL10和URA3基因的切除修复,对非转录链的影响更大。这表明紫外线介导的从头蛋白质合成是高效核苷酸切除修复所必需的,但不是转录链优先修复所必需的。另一方面,环己酰亚胺不影响受抑制的GAL10基因任一条链或URA3基因非转录启动子区域的修复,表明从转录无活性的DNA序列中去除PDs不需要紫外线诱导的从头蛋白质合成。总之,这些数据表明,尽管NTD和NTS通常由GGR子途径修复,但它们对紫外线依赖性从头蛋白质合成的需求不同,这可能表明基因组这些非转录序列中紫外线损伤的处理存在差异。